Fisher & Paykel Healthcare Corporation Limited · NZX:FPH
Fisher & Paykel Healthcare — Non-Deal Roadshow (October 2018)
17 slides from Fisher & Paykel Healthcare's roadshow presentation, Oct 17, 2018
Slide 1: Corporate Governance Roadshow October 2018
v Corporate Governance Roadshow October 2018 Tony Carter Pip Greenwood Chair Director Fisher & Paykel HEALTHCARE
Slide 2: For personal use only
2 For personal use only • • • • • • •
Slide 3: Our Opportunity: Changing Clinical Practice
Our Opportunity: Changing Clinical Practice @ ® A) @ OUR ASPIRATION: RESPIRATORY HUMIDIFICATION | CPAP THERAPY/OSA ee | ade BBs =| DOUBLING. SUPPORT SUPPORT DOUBLING our constant currency revenue every 5-6 years. oon] SHORT-TERM MEDIUM-TERM LONGER-TERM Fisher& Paykel “CONSTANT CURRENCY HEALTHCARE
Slide 4: How we deliver value
How we deliver value Our outputs Increased ‘efficiency of care Improved Over 45 years care & oft ‘outcomes for patients Care by Design Impro through inspi world-leading healthcare Increased shareholder value Benefits to ‘our people Doubling ‘our constant Trusted brand currency revenue every 5-6 year
Slide 5: Board of Directors
Board of Directors O. | Tony Carter Lewis Gradon Michael Daniell Pip Greenwood Geraldine McBride Donal O’Dwyer Scott St John Fisheré.Paykel HEALTHCARE
Slide 6: For personal use only
• For personal use only • − − − • − − • • • 6
Slide 7: Board Remuneration
Board Remuneration Director Fees for year ended 31 March 2018 Remuneration and Quality, Safety Audit & Risk Human Resources Nomination and Regulatory Shares and Total Director Board Fees Committee Committee Committeo! Committee other payments __ remuneration Tony Carter (Chair)? $218,350 $0 $0 $0 $0
Slide 8: Executive Management Team
Executive Management Team fia Lewis Gradon Paul Shearer Andrea Blackie Andrew <q Winston Fong \( ; > f yy Debra Lumsden Brian Schultz Jonti Rhodes Nicholas Fourie Fisher & HEALTHCARE
Slide 9: Executive Management Team
Executive Management Team * Highly-experienced and well respected executive EXECUTIVE MANAGEMENT TEAM TENURE management team - have a collective 125+ years’ IN COMPANY experience in the medical devices industry * Strong result in the Corporate Confidence Index 2018 survey * Close to announcing the a
Slide 10: CEO Remuneration – FY18
• For personal use only CEO Remuneration – FY18 − − − − • • • 10 •
Slide 11: For personal use only
11 For personal use only • • • • • • • • − − −
Slide 12: For personal use only
12 For personal use only • • • • • − − − − −
Slide 13: For personal use only
13 For personal use only • • • • •
Slide 14: Gender diagnostic
For personal use only Statistically powered Do we recruit free of bias? 0% gender diagnostic focussed Do we attract women? on NZ in FY17/FY18. 1.7% FY18 3.2% FY17 Issues identified and actions Assessed the entire Establishment taken to address: employee lifecycle. • Gender pay gap • Higher propo
Slide 15: Diversity Statistics
Diversity Statistics 2017 2018 Women Men ‘Women % Men % Women Men Women % Men % Board 1 7 13% 87% 2 6 25% 75% ‘Senior executives’ 1 8 114 89% 1 8 11% 89% All employees? 1,851 2,135 46% 54% 1,910 2,138 AT% 53% 1. “Senior executive’, as it is used in the table above, refers to the Chief Executive Offi
Slide 16: Ownership Structure
Ownership Structure * Listed on NZX and ASX (NZX.FPH, ASX.FPH) * Currently more than 22,000 shareholders SHAREHOLDING STRUCTURE AS AT 30 JUNE 2018 NZ Institutions m Other Institutions m Brokers & Retail m Other GEOGRAPHICAL OWNERSHIP AS AT 30 JUNE 2018 m™ New Zealand mw Australia mg North America mU
Slide 17: Our Culture reflected in our Purpose, Values & Beliefs
Our Culture reflected in our Purpose, Values & Beliefs %p LIFE We relentlessly focus on improving patients’ lives and strive to provide a high quality of life for our employees ORIGINALITY We encourage origina thinking which leads to e innovi require better products, processes and practices OUR PURP
Fisher & Paykel Healthcare — Non-Deal Roadshow (October 2018) on 6ix